Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions.

classification neuroendocrine tumor orthopedia homeobox prognosis pulmonary carcinoid review

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Oct 2019
Historique:
received: 20 08 2019
revised: 06 09 2019
accepted: 09 09 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 11 10 2019
Statut: epublish

Résumé

Generally, patients with stage I-IIIa (TNM) pulmonary carcinoid disease have a favourable prognosis after curative resection. Yet, distant recurrence of disease after curative surgery occurs in approximately 1-6% of patients with typical carcinoid and 14-29% in patients with atypical carcinoid disease, respectively. Known predictors of distant recurrence of disease are atypical carcinoid, lymphatic involvement, and incomplete resection status. However, none of them can be reliably used, alone or in combination, to exclude patients from long-term follow-up (advised 15 years). By genomic profiling, Orthopedia homeobox (

Identifiants

pubmed: 31597385
pii: cancers11101508
doi: 10.3390/cancers11101508
pmc: PMC6826717
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : KWF Kankerbestrijding
ID : 10956

Déclaration de conflit d'intérêts

Laura Moonen, Jules Derks, and Ernst-Jan Speel declare no conflict of interest. Anne-Marie Dingemans reports grants and personal fees from BMS, personal fees from Roche, personal fees from MSD, personal fees from Eli Lily, personal fees from Takeda, personal fees from Pfizer, personal fees from Boehringer Ingelheim, outside the submitted work.The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results”.

Références

Ann Thorac Surg. 2013 Oct;96(4):1156-1162
pubmed: 23915584
Endocr Pathol. 2019 Mar;30(1):35-42
pubmed: 30523500
Surgery. 2005 Dec;138(6):1137-42; discussion 1142
pubmed: 16360401
J Pathol. 2017 Mar;241(4):488-500
pubmed: 27873319
Oncologist. 2007 May;12(5):535-42
pubmed: 17522241
Cell. 1984 Oct;38(3):675-80
pubmed: 6091896
Nat Commun. 2014 Mar 27;5:3518
pubmed: 24670920
Ann Oncol. 2015 Aug;26(8):1604-20
pubmed: 25646366
Genomics. 1999 Aug 15;60(1):96-104
pubmed: 10458915
Front Biosci (Landmark Ed). 2013 Jan 01;18:740-7
pubmed: 23276958
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):429-44
pubmed: 22531688
J Thorac Oncol. 2018 Jun;13(6):752-766
pubmed: 29454048
Nat Commun. 2019 Aug 20;10(1):3407
pubmed: 31431620
Front Oncol. 2016 Apr 14;6:94
pubmed: 27148486
Endocr Pathol. 2018 Sep;29(3):259-268
pubmed: 29770932
Eur J Cardiothorac Surg. 2007 Feb;31(2):186-91
pubmed: 17140801
Br J Cancer. 2015 Dec 22;113(12):1704-11
pubmed: 26645239
Am J Surg Pathol. 2014 Oct;38(10):1429-36
pubmed: 25046341
Eur J Cancer. 2013 May;49(8):1975-83
pubmed: 23352435
Ann Surg. 2001 Jul;234(1):10-20
pubmed: 11420478
J Thorac Oncol. 2014 Mar;9(3):273-84
pubmed: 24518085
Development. 2007 Dec;134(24):4417-26
pubmed: 18003738
Clin Cancer Res. 2013 Apr 15;19(8):2197-207
pubmed: 23444222
J Thorac Dis. 2017 Nov;9(Suppl 15):S1435-S1441
pubmed: 29201446
Lung. 2015 Apr;193(2):303-8
pubmed: 25680416
J Clin Endocrinol Metab. 2014 Feb;99(2):E374-8
pubmed: 24276465
Ann Oncol. 2012 Oct;23 Suppl 7:vii120-3
pubmed: 22997444
Dev Biol. 2000 Nov 15;227(2):432-49
pubmed: 11071765
Carcinogenesis. 2013 Dec;34(12):2726-37
pubmed: 23929435
Am J Pathol. 2015 Dec;185(12):3164-77
pubmed: 26482608
Lab Invest. 2013 Apr;93(4):408-21
pubmed: 23358112
Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G636-42
pubmed: 16160079
Am J Surg Pathol. 2016 Jun;40(6):738-44
pubmed: 26927888
Thorax. 2014 Jul;69(7):648-53
pubmed: 24603194
Lung. 2017 Dec;195(6):789-798
pubmed: 29022070
Am J Pathol. 2011 Sep;179(3):1129-37
pubmed: 21763262
N Engl J Med. 1992 Oct 29;327(18):1285-8
pubmed: 1406819
Pathol Int. 2013 Mar;63(3):158-68
pubmed: 23530560
Case Rep Pulmonol. 2015;2015:851046
pubmed: 26613062
J Biol Chem. 2006 Dec 29;281(52):39819-30
pubmed: 17090547
Front Neuroanat. 2015 Apr 21;9:47
pubmed: 25954163
J Am Soc Cytopathol. 2019 Jan - Feb;8(1):39-46
pubmed: 30929758
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
Diagn Cytopathol. 2018 Dec;46(12):1010-1014
pubmed: 30284410
Cancer Cytopathol. 2018 Apr;126(4):236-242
pubmed: 29316326
Int J Dev Biol. 2000;44(6):669-77
pubmed: 11061431
Endocr Pathol. 2017 Mar;28(1):60-70
pubmed: 27873160
Thorax. 2007 Mar;62(3):248-52
pubmed: 17099078
Clin Cancer Res. 2018 Apr 1;24(7):1691-1704
pubmed: 29351916
J Thorac Oncol. 2017 Mar;12(3):425-436
pubmed: 27890494
Genes Dev. 1999 Nov 1;13(21):2787-800
pubmed: 10557207

Auteurs

Laura Moonen (L)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6229HX Maastricht, The Netherlands. laura.moonen@mumc.nl.

Jules Derks (J)

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6229HX Maastricht, The Netherlands. j.derks@maastrichtuniversity.nl.

Anne-Marie Dingemans (AM)

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6229HX Maastricht, The Netherlands. a.dingemans@mumc.nl.

Ernst-Jan Speel (EJ)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6229HX Maastricht, The Netherlands. ernstjan.speel@mumc.nl.

Classifications MeSH